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Background/Aims
Post-operative ileus (POI) is a common complication of abdominal surgery. DA-9701, an extract of Pharbitis Semen and Corydalis 
Tuber, is a new prokinetic agent that also alleviates visceral pain. The aim of this study was to investigate whether DA-9701 can 
ameliorate POI in rats. 
Methods
A total of 32 rats were divided into 4 groups: no surgery/no medication (NSNM), no surgery/medication (NSM), surgery/no medication 
(SNM), and surgery/medication (SM). Gastrointestinal transit (GIT), which is assessed by migration of charcoal, and cumulative stool 
weight were measured at 24 hours after surgery. 
Results
GIT was significantly more delayed in the SNM group than in the other groups (SNM vs NSNM, P < 0.001; SNM vs NSM, P < 0.001; 
SNM vs SM, P = 0.005). Cumulative stool weight in that group was also lower than in the no surgery groups (SNM vs NSNM, P = 
0.007; SNM vs NSM, P = 0.033), and there was no significant difference between the SM group and the no surgery groups (SM vs 
NSM, P = 0.703; SM vs NSNM, P = 0.347). 
Conclusion
DA-9701 can ameliorate POI by reducing delayed GIT and improving defecation in a rat model of POI. 
(J Neurogastroenterol Motil 2017;23:109-116)
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Introduction  
Post-operative ileus (POI) is a common complication of ab-
dominal surgery.1,2 Previous studies have shown that POI lasts 
more than four days in more than half of the patients after major 
abdominal surgery, and it lasts for more than 6 days in 25%.3 Al-
though POI is not life-threatening, it involves additional medical 
cost and pain. Therefore, there has been much effort to reduce 
the severity and duration of the complication. Widely approved 
methods for reducing the duration of POI include nil per os, early 
ambulation, minimal use of opioids, and aggressive correction of 
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electrolyte imbalance.1 Despite all these efforts, POI is still a prob-
lematic issue. 
DA-9701 (Motilitone; Dong-A Pharmaceutical Co, Seoul, 
South Korea), a herbal agent obtained from extracts of Pharbitidis 
Semen and Corydalis Tuber, has been reported to have potent pro-
kinetic effects and a good safety profile.4-7 DA-9701 has agonistic 
activity on serotonergic receptors, and antagonistic activity on do-
paminergic receptors; thus it is known to increase gastric emptying 
and accommodation, and to reduce visceral hypersensitivity.8-17 
Pain-induced neural reflexes and postoperative intestinal in-
flammation can induce POI.1 Abdominal pain after surgery can 
lead to the release of endogenous neuromuscular inhibitors, such as 
corticotropin-releasing hormone, norepinephrine, and nitric oxide 
synthase. These inhibitors cause neurogenic bowel inhibition, which 
seems to play a leading part in the pathogenesis of POI. On the 
other hand, surgical manipulation of the intestine can cause local-
ized inflammation and bowel wall edema by activating macrophages 
and mast cells. DA-9701 may reduce the duration and severity of 
POI, via a prokinetic effect in the proximal gastrointestinal (GI) 
tract and by helping to alleviate visceral pain. 
Ghrelin is a peptide synthesized in endocrine cells of the gastric 
mucosa with orexigenic, gastroprokinetic, and anti-inflammatory 
effects.18-21 Circulating ghrelin levels, especially active ghrelin levels, 
decrease under conditions of abdominal surgery22,23 and gradually 
normalize over 24 hours.22,24,25 Therefore, the decrease of ghrelin 
after surgery could be a key driver of POI. Therapeutic effects of 
ghrelin and ghrelin receptor agonists have been shown on surgery-
induced POI.26-29 Meanwhile, a recent study found that acute stress 
can increase plasma acylated ghrelin levels and that DA-9701 nor-
malized the levels.30 On the basis of these observations, we thought 
that DA-9701 might have a normalizing effect on the reduced 
ghrelin levels after surgery.
The aim of this study was to investigate, using rats, whether 
DA-9701 can ameliorate POI. Gastrointestinal function was in-
directly assessed by measuring GI transit (GIT) and stool weight, 
because sustained ileus can result in disturbed stool passage and 
delayed GIT. In addition, we assessed the effect of DA-9701 on 
ghrelin levels by measuring serum ghrelin in the rat model of POI. 
Materials and Methods  
Animals 
All procedures were approved by the Institutional Animal Care 
and Use Committee of Dong-A ST (I-1312011). Male Sprague-
Dawley rats (6-week-old) were purchased from Orient Bio, weigh-
ing 200-220 g. Rats were randomized with 4 rats per cage, and 
maintained in 12 hours alternating light and dark with free access to 
normal rat chow and water. They were kept at constant temperature 
(24 ± 1oC) and 40-60% relative humidity, and were acclimatized 
for 1 week to minimize stress induced by manipulation. After adap-
tive feeding for 1 week, the rats were grouped according to their 
weights and fasted for 12 hours with free access to water. The water 
supply was stopped 3 hours before initiating the experiment (Fig. 1). 
Experimental Groups and Medication
A total of 32 rats were randomly divided into 4 experimental 
groups: no surgery/no medication (NSNM), no surgery/medica-
tion (NSM), surgery/no medication (SNM), and surgery/medica-
tion (SM). The NSNM group served as the control and received 
neither oral administration of DA-9701 nor surgery. The NSM 
group received the drug but did not undergo surgery. The SNM 
Blood sampling
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Day-7
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Figure 1. Schematic diagram of the 
experimental protocol. Pre-op, pre-
operative; Post-op, post-operative; 
NPO, nil per os; GI, gastrointestinal. 
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group did not receive the drug but underwent the surgery, and the 
SM group received the drug and underwent surgery. 
The novel prokinetic agent, DA-9701, was administered orally 
to the medication groups (the NSM and SM groups) 1 hour 
before and 23 hours after surgery. The dose of the test drug was 
3 mg/kg; this dose has been shown to accelerate GIT in previous 
studies.5,7,30 Three percent hydroxypropyl methylcellulose, the ve-
hicle, was administered to the rats in the no medication groups (the 
NSNM and SNM groups) at the same time. The rats received the 
drug by intragastric feeding catheter (oral zonde needle). 
The Operation Protocol
The animals in the surgery groups received an abdominal 
operation, which was carried out according to the following modi-
fied program.2 After anesthesia with ether,31,32 the surgical site was 
shaved and disinfected with povidone iodine. A 3 cm midline lapa-
rotomy was made just lateral to the linea alba. The small intestine 
from the distal duodenum to the distal ileum was exteriorized on 
moist gauze, and was manipulated extensively for 5 minutes. It was 
rolled gently using gloved fingers, enough to compress and move 
the luminal contents but not enough to totally occlude the lumen 
and induce bleeding. Then, the small intestine was covered with 
saline-soaked gauze, and left for 10 minutes. Thereafter, it was re-
turned to the abdominal cavity, and the abdomen and peritoneum 
was sutured with an easy clip applier and disinfected with povidone 
iodine. The animals were allowed to recover from anesthesia on a 
heating pad before being returned to their cages, where they had 
free access to water and rat chow. The rats not subjected to surgery 
were not anesthetized, because ether anesthesia has no effect on 
subsequent gastrointestinal function.33 
Stool Weight
After the abdominal operation, each animal was removed from 
its home cage and placed in a clean and clear metabolic cage. Fecal 
pellets were collected and weighed at 24 hours after surgery. Stool 
weights of the rats not subjected to surgery were measured at the 
same time. The temperature and humidity in the cages remained 
constant for the whole period. 
Measuring Gastrointestinal Transit 
After measuring stool weights, GIT was measured. The GIT 
protocol was modified from published procedures.34,35 Intestinal 
transit was studied in all animals by gavage of 2 mL semisolid 
charcoal solution (5% charcoal and 5% gum arabicum in distilled 
water). The time at which the animals were killed was based on 
previous tests on normal rats. These tests showed that it took 15 
minutes for the charcoal to reach 50 percent of the total length of 
the intestine. Therefore, fifteen minutes after the charcoal meal, the 
rats were killed by neck dislocation and the entire small intestine 
was removed en bloc. The length of the entire small intestine was 
measured by laying it out on a measuring tape and measuring the 
distance from the pyloric sphincter to the ileo-cecal valve. The dis-
tance traveled by the charcoal was also measured from the pyloric 
sphincter to the most caudal edge of the charcoal. The results are 
expressed as the proportion of the length of the entire small intesti-
nal traversed by the charcoal at the time of tissue harvest. 
Measurement of Serum Ghrelin 
Blood samples (0.5 mL) were taken from the infraorbital veins 
of the rats before and 3 hours after surgery, and finally by cardiac 
puncture at 24 hours 15 minutes after surgery, just before the ani-
mals were killed. To minimize stress, the first blood samples were 
obtained under anesthesia immediately before the operation. The 
rats whose blood was sampled 3 hours after being operated were 
isolated from those whose blood were not yet sampled, because 
the stressed rat can lead to anxiety in other rats. Whole blood was 
drawn directly into a tube that contained no anti-coagulant, and Pe-
fabloc was added immediately to a final concentration of 1 mg/mL. 
The blood samples were allowed to clot for 30 minutes at room 
temperature, then centrifuged at 5000 rpm for 15 minutes. The 
supernatants were transferred to separate tubes and acidified with 
HCl to 0.05 N. Total ghrelin and active ghrelin levels in the sera 
were measured with a commercial assay kit (Millipore, ELISA Kit, 
Rat/Mouse Ghrelin, Germany), according to the manufacturer’s 
instructions. 
Statistical Methods
All results were analyzed with SPSS 19.0 (SPSS, Chicago, IL, 
USA). Total and active ghrelin levels were compared using repeat-
ed measures ANOVA and paired t tests. If values did not follow 
a normal distribution, we used nonparametric tests, including the 
Wilcoxon signed rank test. Stool weights and GIT were analyzed 
by two-way ANOVA and one-way ANOVA with post-hoc Tukey’s 
test. If the values did not follow a normal distribution, we used 
nonparametric tests, including the Kruskal-Wallis test with post-
hoc Tukey’s test with ranks. A P < 0.05 was considered to indicate 
statistical significance. 
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Results  
Gastrointestinal Transit 
The mean length of the small intestines was 111.8 ± 4.9 cm 
(range 103-120 cm), and charcoal solution reached 48.2 ± 6.0% 
of the length of the small intestine (range 33-56 cm) in 15 minutes. 
Surgery significantly reduced GIT (main effect of surgery: F [1, 
25] = 18.43, P < 0.001) and there was a main effect of DA-9701 
on GIT (F [1, 25] = 5.17, P = 0.032). GIT in the SNM group 
was more delayed than in the other groups (Fig. 2A) (SNM vs 
NSNM, P < 0.001; SNM vs NSM, P < 0.001; SNM vs SM, 
P = 0.005). There was no difference between the SM group and 
the no surgery (NSNM and NSM) groups (SM vs NSM, P = 
0.739; SM vs NSNM, P = 0.536). The individual values of GIT 
are shown in the table.
Stool Weight
The mean cumulative stool weight was 1.3 ± 1.0 g (range 0.0-
3.2 g). Surgery significantly reduced cumulative stool weight (main 
effect of surgery: F [1, 27] = 9.88, P = 0.004) and there was no 
main effect of DA-9701 on the cumulative stool weight (F [1, 27] 
= 0.36, P = 0.551). The stool weight in the SNM group was 
less than in the no surgery groups (Fig. 2B) (SNM vs NSNM, P 
= 0.007; SNM vs NSM, P = 0.033). There was no difference 
between the SM group and the no surgery groups (SM vs NSM, 
P = 0.703; SM vs NSNM, P = 0.347). Four of the 8 rats in the 
SNM group did not pass stool at all for 24 hours, compared with 
only 1 out of 7 rats in the SM group (Table). 
Active Ghrelin Levels 
There were no inter-group differences in active ghrelin levels 
before the operations (means 128.7/121.5/125.2/126.1 pg/mL in 
the NSNM/NSM/SNM/SM groups, respectively; P = 0.237). 
There were no differences of active ghrelin level according to the 
measurement time (P = 0.288), and there were no interactions 
between time and the groups (P = 0.270). Supplementary Figure 
1 shows that active ghrelin levels had decreased by 3 hours after 
surgery in the surgery groups. The decrease was statistically signifi-
cant in the SNM group (pre-operative [pre-op] vs post-operative 
[post-op] 3 hours, P = 0.013), but not in the SM group (pre-op 
vs post-op 3 hours, P = 0.109). Moreover, the level of active ghre-
lin had not recovered by 24 hours after surgery in the SNM group 
(pre-op vs post-op 24 hours, P = 0.007), whereas it had at least 
partially recovered at 24 hours after surgery in the SM group, and 
the difference between the pre-op and the post-op 24 hours level 
was not significant (P = 0.250). 
Total Ghrelin Levels 
There were no inter-group differences in total ghrelin levels 
before the operations (means 191.1/179.9/182.7/185.0 pg/mL in 
the NSNM/NSM/SNM/SM groups, respectively; P = 0.575). 
There were differences of active ghrelin level according to the mea-
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Figure 2. Gastrointestinal transit (%) and cumulative stool weights (g) by group. (A) Gastrointestinal transit (GIT) was significantly delayed in 
the surgery/no medication (SNM) group compared with the other groups. (B) Cumulative stool weight was significantly lower in the SNM group 
than in the no surgery/no medication (NSNM) and no surgery/medication (NSM) groups. SM, surgery medication. The asterisk (*) indicates a 
statistically significant difference.
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surement time (P < 0.001), and there were significant interactions 
between time and the groups (P = 0.041). Supplementary Figure 2 
shows that the total ghrelin levels at 3 hours after the operations had 
declined in the SM group (pre-op vs post-op 3 hours, P = 0.018) 
and the NSM group (pre-op vs post-op 3 hours, P = 0.011). In 
the SM group only, total ghrelin levels had recovered at 24 hours 
after surgery (post-op 3 hours vs post-op 24 hours, P = 0.001). 
Discussion  
This study showed that there was a main effect of DA-9701 
on GIT. In addition, GIT in the SNM group was slower than in 
the SM group. This means that DA-9701 can reduce the delay 
in GIT after abdominal operations. Although there was no main 
effect of DA-9701 on the cumulative stool weight, the cumulative 
stool weight in the SNM group was significantly lower than in the 
no surgery groups (NSNM + NSM) and there was no difference 
between the SM group and the no surgery group. That is, DA-
9701 may also stimulate the passage of stool after abdominal opera-
tions. During the first post-surgery 24 hours, half of the rats in the 
SNM group did not pass stool at all, compared with only one rat in 
the SM group. This suggests that DA-9701 not only decreases the 
Table. Individual Values of Gastrointestinal Transit and Cumulative Stood Weight in Each Group
Group
Rat
(case No.)
GIT Stool weight
Total length (cm) Length moved (cm) GIT (%) Mean (%) Weight (g) Mean (g)
NSNM   1 - - - 1.92
  2 120 65 54.2 0.83
  3 - - - 2.77
  4 110 55 50.0 3.24
  5 115 60 52.2 2.29
  6 110 61 55.5 1.76
  7 120 62 51.7 1.70
  8 120 61 50.8 52.4 0.23 1.8
NSM   9 105 50 47.6 1.28
10 108 61 56.5 2.46
11 118 57 48.3 3.22
12 110 55 50.0 1.21
13 113 58 51.3 0.93
14 113 59 52.2 0.36
15 103 53 51.5 1.27
16 105 58 55.2 51.6 2.20 1.6
SNM 17 115 45 39.1 2.43
18 110 47 42.7 0
19 110 53 48.2 0.35
20 110 37 33.6 0
21 120 48 40.0 0.74
22 110 36 32.7 0
23 115 58 50.4 0
24 110 45 40.9 41.0 0.16 0.5
SM 25 115 55 47.8 1.38
26 117 53 45.3 0.64
27 - - - -
28 110 58 52.7 1.31
29 110 50 45.5 0.82
30 110 58 52.7 0
31 105 58 55.2 1.50
32 105 47 44.8 49.1 1.76 1.1
GIT, gastrointestinal transit; NSNM, no surgery/no medication; NSM, no surgery/medication; SNM, surgery/no medication; SM, surgery medication.
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severity of POI, but also reduces its duration.
POI can occur due to various factors. Neurogenic bowel 
inhibition and localized postoperative inflammation are the main 
causes.1 The pain-induced neural reflex can contribute to GI inhibi-
tion by generating endogenous opioids and increasing sympathetic 
hyperactivity. Localized tissue trauma and postoperative inflam-
mation can also impair GI motility. In addition, the use of opioids 
in the perioperative period has a negative effect on GI motility. 
The clinical features of POI include nausea, vomiting, abdominal 
distension, inability to tolerate oral feeding, and delayed passage 
of flatus and stool.3 Similarly, the clinical criteria used to define the 
resolution of POI are the passage of stool, return of flatus, absence 
of abdominal distension and pain, absence of nausea or vomiting, 
presence of bowel sounds, and tolerance of an oral diet. In our 
study, we assessed the resolution of POI by measuring GIT and 
stool weights, because judging levels of pain would be highly sub-
jective. 
Many studies have shown that DA-9701 ameliorates visceral 
hypersensitivity, improves bowel movement, and accelerates gastric 
fundus relaxation.5-7,9-15,30 We have already proven that DA-9701 
decreases visceral pain in rats by down-regulating the level of phos-
phorylated extracellular signal-regulated kinase in the dorsal root 
ganglion and spinal cord.12 Kim et al11 also observed that the drug 
increased the pain threshold in rats with colorectal distension-in-
duced visceral hypersensitivity. Other studies have shown that DA-
9701 enhances gastric emptying via stimulation of the serotonin 
type 4 receptor and inhibition of the dopamine D2 receptor.
5,6,13-15,30 
These effects of the drug would probably have helped to improve 
POI in our experiment. 
There has been only one previous study of the effect of DA-
9701 on delayed GIT.5 However, the POI model used involved 
only a 3 cm laparotomy and the incision was closed immediately. 
Our study was designed to overcome this limitation. As we noted in 
the methods section, our operation protocol was intended to provide 
an approximation to a real abdominal operation, and we succeeded 
in demonstrating an effect of DA-9701. In addition, we believe that 
our experimental method was fairly well designed. Thus, we clearly 
observed delayed GIT and reduced volume of stool in the surgery 
groups. In other words, our method of surgery clearly caused POI. 
In addition, there was no problem with the acclimatization of the 
rats in this study, because the groups had very similar mean baseline 
ghrelin levels. This indirectly indicates that identical environmental 
conditions were provided for the rats and they were under similar 
level of stress. 
Our experimental results about serum ghrelin were not encour-
aging. Previous studies have revealed that circulating ghrelin levels, 
especially acyl ghrelin levels, fall in response to abdominal surgery 
and that the levels gradually recover over 24 hours.22-25 We also 
found that ghrelin levels followed this pattern. However, our results 
were more complex and difficult to interpret. 
Active ghrelin levels were reduced at 3 hours after surgery 
in the SNM group and they were not restored by 24 hours after 
surgery. Whereas, in the SM group, they had decreased at 3 hours 
after surgery and partially recovered by 24 hours after surgery, but 
in fact the differences among basal level, 3 hour level, and 24 hour 
level was not statistically significant. At the same time, in the SM 
group, total ghrelin levels were significantly decreased at 3 hours af-
ter surgery but had recovered by 24 hours. Thus, DA-9701 admin-
istration reversed the reduction in ghrelin levels after surgery within 
24 hours. However, we cannot account for the decrease in total 
ghrelin levels at 3 hours after surgery in the NSM group and the 
absence of a decrease of total ghrelin level at 3 hours after surgery 
in the SNM group. Therefore, more work is mandatory to deter-
mine the relationship between ghrelin and DA-9701. Since ghrelin 
is not the only gut hormone determining GIT, it may be helpful to 
research different types of gut hormones, such as nesfatin, motilin, 
and leptin.
Our study has some limitations. First, there were some miss-
ing values. As one rat (No. 27) was killed by mistake during blood 
collection, we could not obtain its GIT and stool weight. Likewise, 
the GIT of 2 other rats could not be measured because the infusion 
syringe became clogged up during gavage of the charcoal solution 
(No. 1) and the small intestine was removed by mistake during 
autopsy (No. 3). Second, the sample sizes were not large enough. 
Further experiments with a larger number of rats are necessary to 
obtain statistically significant results, especially on serum ghrelin 
levels. Third, despite our efforts to minimize environmental effects, 
blood sampling may have been stressful for the animals. Therefore, 
we cannot exclude the possibility that stress affected serum ghrelin 
levels. 
In conclusion, DA-9701 can ameliorate POI by reducing de-
layed GIT and improving defecation in a rat model of POI. There-
fore, DA9701 might be useful as a prokinetic agent for preventing 
POI. These effects of DA-9701 may be associated with alterations 
in ghrelin levels, but further studies are needed.
Supplementary Materials  
Note: To access the supplementary figures mentioned in this 
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